ELAPRASE Trademark

Trademark Overview

On Friday, May 4, 2007, a trademark application was filed for ELAPRASE with the United States Patent and Trademark Office. The USPTO has given the ELAPRASE trademark a serial number of 77173297. The federal status of this trademark filing is REGISTERED AND RENEWED as of Thursday, October 12, 2017. This trademark is owned by Shire Human Genetic Therapies, Inc.. The ELAPRASE trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome
elaprase

General Information

Serial Number77173297
Word MarkELAPRASE
Filing DateFriday, May 4, 2007
Status800 - REGISTERED AND RENEWED
Status DateThursday, October 12, 2017
Registration Number3368560
Registration DateTuesday, January 15, 2008
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, October 30, 2007

Trademark Statements

Indication of Colors claimedThe color(s) black and blue is/are claimed as a feature of the mark.
Description of MarkThe mark consists of the word ELAPRASE in lower-case letters, with the first seven letters shown in black and the last letter shown in blue.
Goods and ServicesPharmaceutical preparations for the treatment of enzyme deficiencies; pharmaceutical preparations for the treatment of Hunter's syndrome

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, May 8, 2007
Primary Code005
First Use Anywhere DateMonday, July 31, 2006
First Use In Commerce DateMonday, July 31, 2006

Trademark Owner History

Party NameShire Human Genetic Therapies, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLexington, MA 02421
Party NameShire Human Genetic Therapies, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 021104104
Party NameShire Human Genetic Therapies, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 021104104

Trademark Events

Event DateEvent Description
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 12, 2017NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Thursday, October 12, 2017REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Thursday, October 12, 2017REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Thursday, October 12, 2017CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, September 12, 2017TEAS SECTION 8 & 9 RECEIVED
Sunday, January 15, 2017COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, March 10, 2013NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Sunday, March 10, 2013REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, March 10, 2013CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, February 21, 2013TEAS SECTION 8 & 15 RECEIVED
Thursday, June 30, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 30, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, October 8, 2009APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, October 8, 2009TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 15, 2008REGISTERED-PRINCIPAL REGISTER
Tuesday, October 30, 2007PUBLISHED FOR OPPOSITION
Wednesday, October 10, 2007NOTICE OF PUBLICATION
Sunday, September 23, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, September 22, 2007ASSIGNED TO LIE
Friday, August 17, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, August 17, 2007USE AMENDMENT ACCEPTED
Friday, August 17, 2007ASSIGNED TO EXAMINER
Thursday, August 16, 2007AMENDMENT TO USE PROCESSING COMPLETE
Thursday, August 16, 2007USE AMENDMENT FILED
Wednesday, August 15, 2007TEAS AMENDMENT OF USE RECEIVED
Tuesday, May 8, 2007NEW APPLICATION ENTERED IN TRAM

Related Keywords

elaprase pharmaceutical treatment preparations syndrome hunter enzyme deficiencies